Physician profile
Thomas L Lambert
NPI 1649222167
$9,463.89
in general payments reported to CMS, 2019-2025
51 companies · $1,641 in 2025
The $1,641 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,974 · 2020: $693 · 2021: $1,333 · 2022: $1,878 · 2023: $1,064 · 2024: $881 · 2025: $1,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,586.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,686.00 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $793.84 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $622.28 | 2019-2025 | Camzyos, Eliquis |
| Kowa Pharmaceuticals America, INC. | $610.88 | 2019-2022 | |
| Boston Scientific Corporation | $484.44 | 2021-2025 | Watchman Flx, Versacross Access Solution, Watchman Access System |
| Sanofi-Aventis U.S. LLC | $444.45 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $418.38 | 2019-2024 | Xarelto |
| Pfizer INC. | $407.60 | 2019-2025 | |
| Abbott Laboratories | $289.08 | 2019-2025 | Aveir, Merlin@Home |
| Arbor Pharmaceuticals, INC. | $271.81 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $233.06 | 2019-2025 | Lifevest |
| Astellas Pharma US INC | $232.08 | 2019-2021 | |
| Abiomed | $225.87 | 2021-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $224.56 | 2019-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $214.91 | 2022-2025 | Verquvo, Capvaxive |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $182.97 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.41 | 2019-2025 | Jardiance |
| Irhythm Technologies, INC. | $136.25 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $132.07 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pacira Pharmaceuticals Incorporated | $121.84 | 2025 | Exparel |
| Esperion Therapeutics, INC. | $120.77 | 2020-2024 | Nexletol |
| Shockwave Medical, INC | $118.34 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kiniksa Pharmaceuticals, LTD. | $115.00 | 2021-2023 | Arcalyst |
| Impulse Dynamics (USA) INC. | $97.84 | 2022 | |
| Alnylam Pharmaceuticals INC. | $87.82 | 2025 | Amvuttra |
| Lexicon Pharmaceuticals, INC. | $87.11 | 2023-2024 | Inpefa |
| Cvrx, INC. | $76.96 | 2024-2025 | Barostim Neo System |
| Bridgebio Pharma, INC. | $75.54 | 2025 | Attruby |
| Medtronic Vascular, INC. | $69.60 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $66.19 | 2019-2022 | |
| Baxter Healthcare | $56.59 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $50.67 | 2024 | Arcalyst |
| Cleerly, INC. | $49.56 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Regeneron Healthcare Solutions, INC. | $45.63 | 2019 | |
| Lundbeck LLC | $45.09 | 2019 | |
| Tactile Systems Technology INC | $41.88 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Chiesi USA, INC. | $33.35 | 2019-2020 | |
| Medtronic, INC. | $31.27 | 2021 | |
| Biotronik INC. | $30.97 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.58 | 2021 | |
| Azurity Pharmaceuticals, INC. | $28.40 | 2023 | Edarbi |
| Atricure, INC. | $27.92 | 2025 | Atriclip Laa Exclusion System |
| Philips North America LLC | $26.78 | 2022 | |
| Edwards Lifesciences Corporation | $23.25 | 2025 | |
| Inogen, INC. | $21.63 | 2025 | |
| Daiichi Sankyo INC. | $21.30 | 2023 | Injectafer |
| Itamar Medical INC | $21.10 | 2023 | Watchpatone |
| Ge Healthcare | $20.43 | 2021 | |
| Lilly USA, LLC | $19.04 | 2021 | |
| Bardy Diagnostics, INC. | $16.00 | 2020 | |
| Acutus Medical, INC. | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.